Evidence map›Paper›PMID 31801289›Full record

ReviewInternational journal of molecular sciences2019

Colon Cancer and Perturbations of the Sphingolipid Metabolism.

Miroslav Machala, Jiřina Procházková, Jiřina Hofmanová, Lucie Králiková, Josef Slavík, Zuzana Tylichová, Petra Ovesná, Alois Kozubík, Jan Vondráček

Open access · goldAbstract readReview
In one paragraph

Review in International journal of molecular sciences, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 42 papers.

0numbers the graph read from it
0cells of the map it votes in
42citing papers in PubMed
2.7field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

42 citing papers in PubMed, 68 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Mechanisms of Abnormal Lipid Metabolism in the Pathogenesis of Disease.International journal of molecular sciences · 2024
    Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Miroslav MachalaDepartment of Chemistry and Toxicology, Veterinary Research Institute, Hudcova 296/70, 62100 Brno, Czech Republic.
Jiřina ProcházkováDepartment of Chemistry and Toxicology, Veterinary Research Institute, Hudcova 296/70, 62100 Brno, Czech Republic.
Jiřina HofmanováDepartment of Cytokinetics, Institute of Biophysics of the Czech Academy of Sciences, Královopolská 135, 61265 Brno, Czech Republic.
Lucie KrálikováDepartment of Chemistry and Toxicology, Veterinary Research Institute, Hudcova 296/70, 62100 Brno, Czech Republic.
Josef SlavíkDepartment of Chemistry and Toxicology, Veterinary Research Institute, Hudcova 296/70, 62100 Brno, Czech Republic.
Zuzana TylichováDepartment of Cytokinetics, Institute of Biophysics of the Czech Academy of Sciences, Královopolská 135, 61265 Brno, Czech Republic.
Petra OvesnáDepartment of Cytokinetics, Institute of Biophysics of the Czech Academy of Sciences, Královopolská 135, 61265 Brno, Czech Republic.
Alois KozubíkDepartment of Cytokinetics, Institute of Biophysics of the Czech Academy of Sciences, Královopolská 135, 61265 Brno, Czech Republic.
Jan VondráčekDepartment of Cytokinetics, Institute of Biophysics of the Czech Academy of Sciences, Královopolská 135, 61265 Brno, Czech Republic.
Czech Academy of Sciences, Institute of Biophysics · CZVeterinary Research Institute · CZ

Funding

Agentura Pro Zdravotnický Výzkum České Republiky 15-30585AMinisterstvo Školství, Mládeže a Tělovýchovy CZ.02.1.01/0.0/0.0/15_003/0000495
6 · The paper itself

Abstract

The development and progression of colorectal cancer (CRC), a major cause of cancer-related death in the western world, is accompanied with alterations of sphingolipid (SL) composition in colon tumors. A number of enzymes involved in the SL metabolism have been found to be deregulated in human colon tumors, in experimental rodent studies, and in human colon cancer cells in vitro. Therefore, the enzymatic pathways that modulate SL levels have received a significant attention, due to their possible contribution to CRC development, or as potential therapeutic targets. Many of these enzymes are associated with an increased sphingosine-1-phosphate/ceramide ratio, which is in turn linked with increased colon cancer cell survival, proliferation and cancer progression. Nevertheless, more attention should also be paid to the more complex SLs, including specific glycosphingolipids, such as lactosylceramides, which can be also deregulated during CRC development. In this review, we focus on the potential roles of individual SLs/SL metabolism enzymes in colon cancer, as well as on the pros and cons of employing the current in vitro models of colon cancer cells for lipidomic studies investigating the SL metabolism in CRC.

Indexed as

Gene Expression Regulation, NeoplasticAcid CeramidaseAlkaline CeramidaseAnimalsCeramidesColonic NeoplasmsDisease Models, AnimalHumansLactosylceramidesLipid MetabolismLysophospholipidsNeutral CeramidasePhosphotransferases (Alcohol Group Acceptor)Proto-Oncogene Proteins c-aktSphingolipidsSphingosineACER2 protein, humanAcid CeramidaseAlkaline CeramidaseASAH1 protein, humanASAH2 protein, humanceramide 1-phosphateCeramidesLactosylceramidesLysophospholipidsNeutral CeramidasePhosphotransferases (Alcohol Group Acceptor)Proto-Oncogene Proteins c-aktSphingolipidsSphingosinesphingosine 1-phosphateSphingosine KinaseSphingosine N-Acyltransferasecolon cancer cellscolon cancer (CRC) sphingolipidomicscolorectal cancerglycosphingolipidlactosylceramidesphingolipidsphingosine-1-phosphate

Identifiers

PMID31801289
PMCPMC6929044
OpenAlexW2990939498

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.